NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-242-2015-1-KR-06 Peptide-Based Methods For Treating Pancreatic Cancer KR National Stage 10-2017-7012656 Pending
NCI E-019-2012-0-US-05 SOLUBLE ENGINEERED MONOMERIC FC US DIV 15/590,981 10633447 Issued PDF
CC E-149-2014-0-US-04 TOPICAL SODIUM NITRITE FORMULATION US National Stage 15/525,557 10272039 Issued PDF
NCI E-113-2016-0-PCT-02 VARIABLE NEW ANTIGEN RECEPTOR (VNAR) ANTIBODIES AND ANTIBODY CONJUGATES TARGETING TUMOR AND VIRAL ANTIGENS PCT PCT PCT/US17/031758 Abandoned
NIBIB E-150-2016-0-PCT-02 Chemical Conjugates of Evans Blue Derivatives and Their Use as Radiotherapy and Imaging Agents PCT PCT PCT/US17/031696 Expired
NCI E-093-2013-2-US-10 COMPOUNDS FOR INHIBITING DRUG-RESISTANT STRAINS OF HIV-1 INTEGRASE US DIV 15/589,590 10208035 Issued PDF
NHLBI E-201-2016-0-PCT-02 Annuloplasty Procedures, Related Devices And Methods PCT PCT PCT/US2017/031543 Expired
NCI E-226-2014-0-US-07 HUMAN ANTI-THYROGLOBULIN T CELL RECEPTORS US National Stage 15/524,869 10450372 Issued PDF
NIBIB E-099-2015-0-US-02 Labeled Evans Blue Dye Derivative For In Vivo Serum Albumin Labeling US DIV 15/587,948 10258701 Issued PDF
NIEHS E-179-2016-2-PCT-01 Methods for Improving Drug Delivery Across the Blood-Brain Barrier PCT PCT COMB PCT/US2017/031206 Expired
NCI E-271-2014-0-US-02 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof US National Stage 15/524,567 1028-03-07 Issued PDF
NIBIB E-149-2016-0-PCT-02 Albumin-binding Immunodulatory Compositions And Methods Of Use Thereof PCT PCT PCT/US2017/031098 Expired
NHLBI E-156-2016-0-PCT-02 ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS PCT PCT PCT/US2017/030808 Expired
NIAID E-061-2016-0-PCT-02 NEUTRALIZING ANTIBODIES TO INFLUENZA HA AND THEIR USE AND IDENTIFICATION PCT PCT PCT/US17/030641 Expired
NCI E-261-2016-0-US-04 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer US National Stage 15/523,670 10213445 Issued PDF
NCI E-123-2017-0-PCT-01 Antitumor Effect Of Cryptotanshinone PCT PCT PCT/US2017/030424 Expired
NHGRI E-044-2013-1-AU-03 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA AU National Stage 2017258642 Issued
NHGRI E-044-2013-1-NZ-14 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA NZ National Stage 747685 Issued
NHGRI E-044-2013-1-IN-10 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA IN National Stage 201847043433 Issued
NHGRI E-044-2013-1-EA-08 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA EA National Stage 201892467 Issued
NHGRI E-044-2013-1-CO-07 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA CO National Stage NC2018/0012873 Issued
NHGRI E-044-2013-1-JP-11 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA JP National Stage 2019-508165 Issued
NHGRI E-044-2013-1-KR-12 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA KR National Stage 10-2018-7034615 Issued
NICHD E-039-2016-1-AU-03 Treatment of Hormonal Disorders of Growth AU National Stage 2015346277 Issued
NIDA E-073-2013-0-AU-07 Potent and Selective Inhibitors Of Monoamine Transporters; Method of Making; and Use Thereof AU DIV 2017202849 Issued
NIAID E-043-2010-0-US-06 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof US CON 15/581,603 10100346 Issued PDF
NHGRI E-044-2013-1-PCT-02 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA PCT PCT PCT/US2017/030174 Expired
NHGRI E-044-2013-1-CN-06 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA CN National Stage 201780040785.7 Pending
NHGRI E-044-2013-1-EP-09 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA EP National Stage 17735676.3 Pending
NHGRI E-044-2013-1-SG-15 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SG National Stage 11201809468X Pending
NHGRI E-044-2013-1-CA-05 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA CA National Stage 3022303 Pending
NHGRI E-044-2013-1-BR-04 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA BR National Stage BR1120180722790 Pending
NHGRI E-044-2013-1-MX-13 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA MX National Stage MX/A/2018/013157 Pending
NIAMS E-216-2010-0-US-07 Compositions and Methods for Treating or Preventing Lupus US CON 15/498,202 10017762 Issued PDF
NHLBI E-124-2014-3-PCT-02 Device For Closure Of Transvascular Or Transcameral Access Ports PCT PCT PCT/US2017/029094 Expired
NHLBI E-124-2014-3-JP-05 Device For Closure Of Transvascular Or Transcameral Access Ports JP National Stage 2019-507068 Pending
NIAID E-124-2016-0-PCT-02 BIVALENT IMMUNOGENIC CONJUGATE FOR MALARIA AND TYPHOID PCT PCT PCT/US17/029182 Expired
NHLBI E-124-2014-3-EP-06 Device For Closure Of Transvascular Or Transcameral Access Ports EP National Stage 17786794.2 Pending
NIDDK E-138-2017-0-AU-03 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS AU National Stage 2017254720 Issued
NIDDK E-138-2017-0-KR-16 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS KR National Stage 10-2018-7033797 Issued
NIDDK E-138-2017-0-MX-10 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS MX National Stage MX/a/2018/012655 Issued
NIDDK E-138-2017-0-CN-14 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS CN National Stage 201780024816.X Issued
NICHD E-552-2013-0-US-13 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE US CON 15/493,622 10113183 Issued PDF
NIDDK E-138-2017-0-PCT-02 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS PCT PCT PCT/US2017/028996 Expired
NIDDK E-138-2017-0-HK-17 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS HK EP 19127110.5 Pending
NIDDK E-138-2017-0-JP-09 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS JP National Stage 2018-555672 Pending
NIDDK E-138-2017-0-IN-15 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS IN National Stage 201817040537 Pending
NIDDK E-138-2017-0-KR-01 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS KR DIV 10-2022-7032219 Pending
NIDDK E-138-2017-0-ZA-12 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS ZA National Stage 2018/06713 Pending
NIDDK E-138-2017-0-CA-13 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS CA National Stage 3020490 Pending